Pharmacogenomics-based diagnostics are being increasing adopted by pharmaceutical, biotech organizations, clinical centers and hospitals to reduce trial lag in their efforts to discover new therapeutics and qualify parameters to help infer effectiveness of clinical recommendations to diverse patient groups. Microarray and RT-PCR based testing approaches are ideal platforms to solve both complex and simple diagnostic questions as large number of candidate genes can be analyzed for a particular study program.

How we can add value?

• We can handle the complete study design and program for qualifying relevant biomarkers, which are related to a medical or biological aspect being studied. We can propose disease pathways which these markers are likely to be involved with. Biomarkers developed along with novel compounds are an important companion for your clinical program.
• We take care of complete study design including qPCR, SNP analysis and gene expression profiling. We provide comprehensive qPCR services on both FFPE and frozen samples of any range. Being a platform-independent solutions partner, we can share our broad experience on a variety of platforms and study design, which will be best suited for your area of research.
• Detailed functional analysis would be done by our Bioinformatics and Biostatistical experts, starting from gene selection, clustering and pathway predictions.

Please refer to our Services section for a detailed presentation on our range.